Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Hyrulean King who wrote (2047)	6/29/1998 10:02:00 AM
From: Striyker	Read Replies (1) \| Respond to of 5402

Look at this rediculous spread! .75 X .875

To: Hyrulean King who wrote (2047)	6/29/1998 6:00:00 PM
From: Mr. Forthright	Read Replies (4) \| Respond to of 5402

Good evening to you all. Let's start establishing a valuation model for SGNC. In order to determine the current value of SGNC we first have to establish the size of the potential future cash flows/earnings, discount them and risk adjust them. The valuation model I will use is pretty standard. I will ask for one variable a day, offering an opportunity for everyone to discuss the said variable. At the end of the week YOU guys will have come up with the current value of SGNC. Ready? 1) What is the total market potential for synthetic red blood cell products?